LD-2 disclosure · 4th Quarter - Report
CELGENE CORPORATION
Client
- Location
- New Jersey · United States of America
Registrant
- Description
- 8/1/2004
- Location
- Summit, New Jersey, United States of America
Lobbying activities
3 issuesCopyright/Patent/Trademark
S. 1390, "STRONGER Patents Act of 2017", provisions regarding patent reform.
LobbyistsPATRICK GLIHA · MATTHEW SCHUMAKER · ERIN POLAK
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
H.R. 1, "Tax Cuts and Jobs Act", provisions regarding corporate tax reform.
LobbyistsPATRICK GLIHA · ERIN POLAK
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
H.R. 2051, "FAST Generics Act of 2017", provisions regarding REMS. H.R. 1409, "Cancer Drug Parity Act of 2017", regarding all provisions. H.R. 2077, "Restoring the Patient's Voice Act of 2017", Step Therapy / Fail First. S. 974/ H.R. 2212, "CREATES Act of 2017", provisions regarding REMS. H.R. 849, "Protecting Seniors' Access to Medicare Act of 2017", regarding IPAB. Issues relating to Medicare Part D / Part B and the Affordable Care Act. Regulation of Non-Biological Complex Drugs. Issues relating to cancer drug coverage parity.
LobbyistsPATRICK GLIHA · MATTHEW SCHUMAKER · ERIN POLAK
SENATE · HOUSE OF REPRESENTATIVES